Arvida Group
- Home ›
- NZ ›
- Healthcare
Arvida Group Limited, together with its subsidiaries, owns, develops, and operates retirement villages and rest homes for the elderly in New Zealand. The last earnings update was 145 days ago. More info.
Add to Portfolio Compare Print
ARV Share Price and Events
7 Day Returns
1 Year Returns
ARV Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Arvida Group (ARV) | 0% | 0.8% | -3% | 11.2% | 17.3% | - |
| NZ Healthcare | 3.8% | 1.8% | 3% | 9.1% | 28.1% | 63.2% |
| NZ Market | 1.4% | 4.5% | 6.6% | 12.3% | 23.9% | 48% |
1 Year Return vs Industry and Market
- ARV outperformed the Healthcare industry which returned 9.1% over the past year.
- ARV underperformed the Market in New Zealand which returned 12.3% over the past year.
Value
Is Arvida Group undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Arvida Group
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Arvida Group.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 2 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 7.8% |
| Perpetual Growth Rate | 10-Year NZ Government Bond Rate | 2.4% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year NZ Govt Bond Rate | 2.4% |
| Equity Risk Premium | S&P Global | 6% |
| Healthcare Unlevered Beta | Simply Wall St/ S&P Global | 0.71 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.711 (1 + (1- 28%) (28.28%)) |
0.904 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.9 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.37% + (0.904 * 5.96%) |
7.76% |
Discounted Cash Flow Calculation for NZSE:ARV using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Arvida Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (NZD, Millions) | Source |
Present Value Discounted (@ 7.76%) |
|
|---|---|---|---|
| 2019 | 20.91 | Est @ 88.72% | 19.40 |
| 2020 | 34.04 | Est @ 62.82% | 29.32 |
| 2021 | 49.25 | Est @ 44.68% | 39.36 |
| 2022 | 65.01 | Est @ 31.99% | 48.22 |
| 2023 | 80.02 | Est @ 23.1% | 55.09 |
| 2024 | 93.54 | Est @ 16.88% | 59.75 |
| 2025 | 105.25 | Est @ 12.53% | 62.40 |
| 2026 | 115.23 | Est @ 9.48% | 63.40 |
| 2027 | 123.70 | Est @ 7.35% | 63.16 |
| 2028 | 130.94 | Est @ 5.85% | 62.04 |
| Present value of next 10 years cash flows | NZ$502.14 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= NZ$130.94 × (1 + 2.37%) ÷ (7.76% – 2.37%) |
NZ$2,489.22 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= NZ$2,489.22 ÷ (1 + 7.76%)10 |
NZ$1,179.47 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= NZ$502.14 + NZ$1,179.47 |
NZ$1,681.61 |
| Equity Value per Share (NZD) |
= Total value / Shares Outstanding
= NZ$1,681.61 / 413.95 |
NZ$4.06 |
| Calculation | Result | |
|---|---|---|
| Value per share (NZD) | From above. | NZ$4.06 |
| Current discount | Discount to share price of
NZ$1.29
= -1 x (NZ$1.29 - NZ$4.06) / NZ$4.06 |
68.2% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- Arvida Group's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Arvida Group's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Arvida Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Arvida Group's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-09-30) in NZD | NZ$0.18 |
| NZSE:ARV Share Price ** | NZSE (2019-04-18) in NZD | NZ$1.29 |
| New Zealand Healthcare Industry PE Ratio | Median Figure of 7 Publicly-Listed Healthcare Companies | 11x |
| New Zealand Market PE Ratio | Median Figure of 90 Publicly-Listed Companies | 17.72x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Arvida Group.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NZSE:ARV Share Price ÷ EPS (both in NZD) = 1.29 ÷ 0.18 |
7.19x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Arvida Group is good value based on earnings compared to the NZ Healthcare industry average.
- Arvida Group is good value based on earnings compared to the New Zealand market.
Price based on expected Growth
Does
Arvida Group's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 7.19x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts |
-19.4%per year |
| New Zealand Healthcare Industry PEG Ratio | Median Figure of 7 Publicly-Listed Healthcare Companies | 0.99x |
| New Zealand Market PEG Ratio | Median Figure of 66 Publicly-Listed Companies | 1.5x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 7.19x ÷ -19.4% |
-0.37x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Arvida Group earnings are not expected to grow next year, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Arvida Group's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-09-30) in NZD | NZ$1.29 |
| NZSE:ARV Share Price * | NZSE (2019-04-18) in NZD | NZ$1.29 |
| New Zealand Healthcare Industry PB Ratio | Median Figure of 7 Publicly-Listed Healthcare Companies | 1.17x |
| New Zealand Market PB Ratio | Median Figure of 126 Publicly-Listed Companies | 1.55x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NZSE:ARV Share Price ÷ Book Value per Share (both in NZD) = 1.29 ÷ 1.29 |
1x |
* Primary Listing of Arvida Group.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Arvida Group is good value based on assets compared to the NZ Healthcare industry average.
Value checks
We assess Arvida Group's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check) Arvida Group has a total score of 5/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
How is Arvida Group expected to perform in the next 1 to 3 years based on estimates from 2 analysts?
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Arvida Group's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.4%.
Growth vs Market Checks
- Arvida Group's earnings are expected to decrease over the next 1-3 years, this is below the New Zealand market average.
- Arvida Group's revenue growth is expected to exceed the New Zealand market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NZSE:ARV Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts | -19.4% |
| NZSE:ARV Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts | 6.1% |
| New Zealand Healthcare Industry Earnings Growth Rate | Market Cap Weighted Average | 9.8% |
| New Zealand Healthcare Industry Revenue Growth Rate | Market Cap Weighted Average | 10.2% |
| New Zealand Market Earnings Growth Rate | Market Cap Weighted Average | 6.1% |
| New Zealand Market Revenue Growth Rate | Market Cap Weighted Average | 5% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (6 months ago) | See Below |
| Future Estimates | Average of up to 2 Analyst Estimates (S&P Global) | See Below |
| Date (Data in NZD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-03-31 | 172 | 39 | 2 | |
| 2020-03-31 | 161 | 36 | 2 | |
| 2019-03-31 | 152 | 45 | 2 |
| Date (Data in NZD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-09-30 | 148 | 65 | 74 |
| 2018-06-30 | 140 | 60 | 66 |
| 2018-03-31 | 132 | 54 | 58 |
| 2017-12-31 | 123 | 46 | 53 |
| 2017-09-30 | 115 | 39 | 49 |
| 2017-06-30 | 108 | 39 | 51 |
| 2017-03-31 | 101 | 40 | 54 |
| 2016-12-31 | 96 | 34 | 45 |
| 2016-09-30 | 90 | 27 | 36 |
| 2016-06-30 | 86 | 26 | 30 |
| 2016-03-31 | 83 | 24 | 24 |
| 2015-12-31 | 71 | 22 | 17 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (6 months ago) | See Below |
| Future Estimates | Average of up to 2 Analyst Estimates (S&P Global) | See Below |
All data from Arvida Group Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in NZD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-03-31 | 0.09 | 0.11 | 0.08 | 2.00 |
| 2020-03-31 | 0.09 | 0.10 | 0.07 | 2.00 |
| 2019-03-31 | 0.11 | 0.12 | 0.09 | 2.00 |
| Date (Data in NZD Millions) | EPS * |
|---|---|
| 2018-09-30 | 0.18 |
| 2018-06-30 | 0.17 |
| 2018-03-31 | 0.16 |
| 2017-12-31 | 0.15 |
| 2017-09-30 | 0.15 |
| 2017-06-30 | 0.16 |
| 2017-03-31 | 0.18 |
| 2016-12-31 | 0.16 |
| 2016-09-30 | 0.13 |
| 2016-06-30 | 0.11 |
| 2016-03-31 | 0.09 |
| 2015-12-31 | 0.08 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Arvida Group's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the New Zealand market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the New Zealand market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Arvida Group has a total score of 1/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Arvida Group performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Arvida Group has delivered over 20% year on year earnings growth in the past 5 years.
- Arvida Group's 1-year earnings growth exceeds its 5-year average (51.2% vs 49.6%)
- Arvida Group's earnings growth has exceeded the NZ Healthcare industry average in the past year (51.2% vs -4.6%).
Earnings and Revenue History
All data from Arvida Group Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in NZD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-09-30 | 147.95 | 73.67 | 0.59 | |
| 2018-06-30 | 140.12 | 65.66 | 0.59 | |
| 2018-03-31 | 132.30 | 57.64 | 0.59 | |
| 2017-12-31 | 123.43 | 53.19 | 0.55 | |
| 2017-09-30 | 114.56 | 48.74 | 0.52 | |
| 2017-06-30 | 108.00 | 51.20 | 0.52 | |
| 2017-03-31 | 101.43 | 53.67 | 0.52 | |
| 2016-12-31 | 95.80 | 44.87 | 0.45 | |
| 2016-09-30 | 90.17 | 36.07 | 0.39 | |
| 2016-06-30 | 86.34 | 30.05 | 0.39 | |
| 2016-03-31 | 82.51 | 24.02 | 0.39 | |
| 2015-12-31 | 70.64 | 17.45 | 0.25 | |
| 2015-09-30 | 58.77 | 10.88 | 0.11 | |
| 2015-06-30 | 39.42 | 6.98 | 0.11 | |
| 2015-03-31 | 20.07 | 3.08 | 0.11 | |
| 2014-03-31 | -0.80 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Arvida Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Arvida Group used its assets more efficiently than the NZ Healthcare industry average last year based on Return on Assets.
- Arvida Group's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Arvida Group's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Arvida Group has a total score of 4/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Arvida Group's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Arvida Group's finances.
The net worth of a company is the difference between its assets and liabilities.
- Arvida Group's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Arvida Group's long term commitments exceed its cash and other short term assets.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Debt is not covered by short term assets, assets are 0.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Arvida Group Company Filings, last reported 6 months ago.
| Date (Data in NZD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-09-30 | 532.05 | 150.99 | 2.46 |
| 2018-06-30 | 532.05 | 150.99 | 2.46 |
| 2018-03-31 | 510.46 | 123.08 | 3.13 |
| 2017-12-31 | 510.46 | 123.08 | 3.13 |
| 2017-09-30 | 378.68 | 110.12 | 1.86 |
| 2017-06-30 | 378.68 | 110.12 | 1.86 |
| 2017-03-31 | 371.55 | 73.50 | 1.30 |
| 2016-12-31 | 371.55 | 73.50 | 1.30 |
| 2016-09-30 | 284.71 | 32.36 | 1.72 |
| 2016-06-30 | 284.71 | 32.36 | 1.72 |
| 2016-03-31 | 264.76 | 13.25 | 1.80 |
| 2015-12-31 | 264.76 | 13.25 | 1.80 |
| 2015-09-30 | 252.69 | 10.00 | 1.08 |
| 2015-06-30 | 252.69 | 10.00 | 1.08 |
| 2015-03-31 | 209.72 | 7.31 | 1.84 |
| 2014-03-31 | 0.02 | 0.00 | 0.89 |
- Arvida Group's level of debt (28.4%) compared to net worth is satisfactory (less than 40%).
- Unable to establish if Arvida Group's debt level has increased without past 5-year debt data.
- Debt is well covered by operating cash flow (43.3%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 6.1x coverage).
Financial health checks
We assess Arvida Group's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Arvida Group has a total score of 3/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Arvida Group's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
NZ$2,000 of
Arvida Group
shares you are expected to receive
NZ$74
in your first year as a dividend.
Dividend Amount
- Arvida Group's pays a higher dividend yield than the bottom 25% of dividend payers in New Zealand (3.23%).
- Arvida Group's dividend is below the markets top 25% of dividend payers in New Zealand (5.65%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 2 Analyst Estimates (S&P Global) | See Below |
| New Zealand Healthcare Industry Average Dividend Yield | Market Cap Weighted Average of 7 Stocks | 2.5% |
| New Zealand Market Average Dividend Yield | Market Cap Weighted Average of 75 Stocks | 3.8% |
| New Zealand Minimum Threshold Dividend Yield | 10th Percentile | 1.9% |
| New Zealand Bottom 25% Dividend Yield | 25th Percentile | 3.2% |
| New Zealand Top 25% Dividend Yield | 75th Percentile | 5.7% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in NZ$) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2021-03-31 | 0.06 | 2.00 |
| 2020-03-31 | 0.06 | 2.00 |
| 2019-03-31 | 0.05 | 2.00 |
| Date (Data in NZ$) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2018-05-28 | 0.048 | 3.631 |
| 2017-11-21 | 0.046 | 3.753 |
| 2017-06-06 | 0.046 | 3.631 |
| 2017-05-23 | 0.046 | 3.385 |
| 2016-11-23 | 0.044 | 3.396 |
| 2016-08-18 | 0.044 | 3.768 |
| 2016-06-07 | 0.044 | 3.741 |
| 2016-05-25 | 0.044 | 3.608 |
| 2015-11-26 | 0.042 | 4.384 |
| 2015-05-28 | 0.010 | 1.195 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Whilst dividend payments have been stable, Arvida Group has been paying a dividend for less than 10 years.
- Dividend payments have increased, but Arvida Group only paid a dividend in the past 4 years.
Income/ dividend checks
We assess Arvida Group's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.9%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Arvida Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Arvida Group has a total score of 3/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
CEO Bio
Mr. William Adam McDonald, also known as Bill, B.Bus, MAgribus serves as the Chief Executive Officer of Arvida Group Limited. Mr. McDonald joined Arvida as a consultant in September 2014. He is an experienced retirement and aged care specialist with 12 years participation in the sector. He entered the aged care and retirement industry as acting Chief Executive Officer for a community owned organisation in country Victoria. Having successfully guided the organisation through the accreditation process, he was approached by the Buxton Group to assist in the development of an exclusive retirement housing brand. He joined Stockland in the executive role of Regional Operations Manager for Victoria, operating Stockland's 24 retirement villages. He played a key directional role for the business as a member of the State Executive Committee. In January 2011, he was General Manager of ING's retirement assets division in New Zealand. In this role he operated and improved the villages and aged care facilities with a focus on preparing the business for its sale in November 2011.
CEO Compensation
- Insufficient data for Bill to compare compensation growth.
- Insufficient data for Bill to establish whether their remuneration is reasonable compared to companies of similar size in New Zealand.
Management Team
Bill McDonald
Chief Executive Officer
Jeremy Nicoll
Chief Financial Officer
Tristan Saunders
General Manager of Sales & Marketing
Teresa Seux
General Manager of Human Resources
Adil Kapadia
Head of IT
0.9 yrs
Board of Directors Tenure
Average tenure of the Arvida Group board of directors in years:
- The tenure for the Arvida Group board of directors is about average.
Board of Directors
Peter Wilson
Independent Chairman
77
4.4 yrs
Anthony Beverley
Independent Director
Paul Ridley-Smith
Independent Director
3.9 yrs
Michael Ambrose
Independent Director
5.3 yrs
Susan Paterson
Independent Director
61
3.9 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (NZ$) | Value (NZ$) | |
|---|---|---|---|---|---|---|---|---|---|---|
Management checks
We assess Arvida Group's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Arvida Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Arvida Group Limited (NZSE:ARV): Time For A Financial Health Check
While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Assessing first and foremost the financial health is. … Let's work through some financial health checks you may wish to consider if you're interested in this stock.
Simply Wall St - – Full articleDid Arvida Group's (NZSE:ARV) Share Price Deserve to Gain 35%?
For example, Arvida Group Limited (NZSE:ARV) shareholders have seen the share price rise 35% over three years, well in excess of the market return (23%, not including dividends). … One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). … During three years of share price growth, Arvida Group achieved compound earnings per share growth of 46% per year.
Simply Wall St - – Full articleWhy I Like Arvida Group Limited (NZSE:ARV)
Attractive stocks have exceptional fundamentals. … In the case of Arvida Group Limited (NZSE:ARV), there's. … trading at a great value
Simply Wall St - – Full articleDo Institutions Own Arvida Group Limited (NZSE:ARV) Shares?
A look at the shareholders of Arvida Group Limited (NZSE:ARV) can tell us which group is most powerful. … Arvida Group is not a large company by global standards. … institutional investors have bought into the company.
Simply Wall St - – Full articleIs Arvida Group Limited’s (NZSE:ARV) 1.6% ROCE Any Good?
Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. … Return On Capital Employed (ROCE): What is it? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.
Simply Wall St - – Full articleShould You Buy Arvida Group Limited (NZSE:ARV) For Its Dividend?
A large part of investment returns can be generated by dividend-paying stock given their role in compounding returns over time. … Arvida Group Limited (NZSE:ARV) has recently paid dividends to shareholders, and currently yields 3.6%. … Does Arvida Group tick all the boxes of a great dividend stock?
Simply Wall St - – Full articleHere's What Arvida Group Limited's (NZSE:ARV) P/E Ratio Is Telling Us
We'll look at Arvida Group Limited's (NZSE:ARV) P/E ratio and reflect on what it tells us about the company's share price. … Arvida Group has a P/E ratio of 7.14, based on the last twelve months. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleWhat You Must Know About Arvida Group Limited's (NZSE:ARV) Financial Strength
Investors are always looking for growth in small-cap stocks like Arvida Group Limited (NZSE:ARV), with a market cap of NZ$538m. … However, an important fact which most ignore is: how financially healthy is the business?
Simply Wall St - – Full articleWhat Type Of Shareholder Owns Arvida Group Limited's (NZSE:ARV)?
Every investor in Arvida Group Limited (NZSE:ARV) should be aware of the most powerful shareholder groups. … Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. … Arvida Group is not a large company by global standards.
Simply Wall St - – Full articleArvida Group Limited (NZSE:ARV): Why Return On Capital Employed Is Important
and want to begin learning the link between Arvida Group Limited (NZSE:ARV)’s return fundamentals and stock market performance. … To understand Arvida Group’s capital returns we will look at a useful metric called return on capital employed. … Arvida Group's Return On Capital Employed
Simply Wall St - – Full articleCompany Info
Description
Arvida Group Limited, together with its subsidiaries, owns, develops, and operates retirement villages and rest homes for the elderly in New Zealand. It operates approximately 26 retirement villages with 1,446 aged care beds and 1,301 retirement units. The company was formerly known as Hercules Limited. Arvida Group Limited was founded in 2014 and is based in Auckland, New Zealand.
Details
| Name: | Arvida Group Limited |
| ARV | |
| Exchange: | NZSE |
| Founded: | 2014 |
| NZ$533,995,296 | |
| 413,949,842 | |
| Website: | http://www.arvida.co.nz |
| Address: |
Arvida Group Limited 39 Market Place, Level 1, Auckland, 1010, New Zealand |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NZSE | ARV | Ordinary Shares | New Zealand Stock Exchange | NZ | NZD | 18. Dec 2014 |
Number of employees
Current staff
Industry
| Health Care Facilities | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/21 10:35 |
| End of day share price update: | 2019/04/18 00:00 |
| Last estimates confirmation: | 2019/03/31 |
| Last earnings filing: | 2018/11/27 |
| Last earnings reported: | 2018/09/30 |
| Last annual earnings reported: | 2018/03/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
